BioCentury
ARTICLE | Clinical News

Liprotamase: Phase III started

October 12, 2015 7:00 AM UTC

Anthera began the open-label, international Phase III SOLUTION trial to compare oral Sollpura vs. oral porcine-derived pancreatic enzyme replacement therapy (PERT) in about 130 patients. Anthera has e...